10x Genomics (TXG) Preferred Stock Liabilities (2018 - 2019)
10x Genomics recorded quarterly Preferred Stock Liabilities of $243.2 million in Q2 2019, little changed quarter-over-quarter from $243.2 million in Q1 2019.
10x Genomics' Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $243.2 million for Q2 2019.
- In Q2 2019, Preferred Stock Liabilities changed N/A year-over-year to $243.2 million; the TTM figure through Jun 2019 stood at $243.2 million (changed N/A YoY), while the FY2018 annual figure was $243.2 million, up 53.55% from the prior year.
- Preferred Stock Liabilities came in at $243.2 million for Q2 2019 at 10x Genomics, roughly flat from $243.2 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $243.2 million in Q4 2018 to a low of $208.3 million in Q3 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 199.87 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Teladoc Health | 1.42 Bn | 672.39 Mn | 562.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 243.24 Mn |
| Mar 31, 2019 | 243.24 Mn |
| Dec 31, 2018 | 243.24 Mn |
| Sep 30, 2018 | 208.29 Mn |